Gyno-Tardyferon (Folic Acid, Dried Ferrous Sulfate)

Gyno‑Tardyferon is indicated for the prophylaxis and management of specific anemic conditions related to iron and folate deficiency.

• Prevention of iron‑deficiency anemia in menstruating women.
• Treatment of mild to moderate folate deficiency.
• Support of maternal iron and folate status during early pregnancy.
• Adjunct to dietary measures in individuals with increased nutritional needs, such as athletes or those on restrictive diets.
• Prevention of anemia in patients undergoing chronic blood loss, e.g., after minor surgery.
• Supplementation for women with a history of recurrent pregnancy loss associated with low folate levels.

The safety profile of Gyno‑Tardyferon reflects the typical reactions observed with oral iron and folic acid preparations.

Common

• Mild gastrointestinal discomfort such as nausea or abdominal cramping.
• Transient darkening of stools due to iron content.
• Occasional headache or dizziness.
• Slight metallic taste in the mouth.
• Loose stools or mild diarrhea.
• Increased frequency of urination (occasionally).

Serious

• Allergic reactions including rash, itching, or swelling of the face and throat.
• Severe constipation or intestinal obstruction requiring medical attention.
• Iron overload in patients with hereditary hemochromatosis may occur and require monitoring.
• Worsening of folate deficiency symptoms such as megaloblastic anemia if dosing is excessive.

When using Gyno‑Tardyferon, certain precautions should be observed to minimize risks and ensure optimal benefit.

• Assess iron status before initiating therapy to avoid unnecessary supplementation.
• Use with caution in individuals with known hypersensitivity to ferrous sulfate or folic acid.
• Avoid use in patients with hereditary hemochromatosis or other iron‑overload disorders.
• Monitor folate levels in patients with malabsorption syndromes or on anticonvulsant therapy.
• Pregnant or breastfeeding women should consult a healthcare professional before starting supplementation.
• Keep out of reach of children; accidental ingestion of large amounts can be harmful.
• Do not exceed the recommended daily dose without medical advice.

Gyno‑Tardyferon may interact with certain medicines, affecting absorption or therapeutic effect.

Avoid

• Concurrent use with tetracycline antibiotics, which can chelate iron and reduce antibiotic efficacy.
• Simultaneous intake of levothyroxine, as iron may impair thyroid hormone absorption.
• Co‑administration with quinolone antibiotics (e.g., ciprofloxacin) that bind iron and lower antibiotic levels.

Use with caution

• Antacids or proton‑pump inhibitors, which may decrease iron absorption; spacing doses by at least two hours is advised.
• Methotrexate therapy, where folic acid supplementation can mask toxicity; monitor closely.
• Vitamin C supplements, which enhance iron absorption and may increase gastrointestinal side effects.